Platensimycin
Platensimycin
Platensimycin (pronounced pla-ten-si-my-cin) is a novel antibiotic compound that was discovered by scientists at Merck Research Laboratories in 2006. It is derived from the Streptomyces platensis species of bacteria and has shown significant potential in the treatment of bacterial infections.
Etymology
The term "Platensimycin" is derived from the name of the bacteria from which it was isolated, Streptomyces platensis. The suffix "-mycin" is commonly used in the naming of antibiotic substances, originating from the Greek word "mykes" meaning fungus, as many antibiotics were originally derived from fungal species.
Mechanism of Action
Platensimycin works by inhibiting the enzyme FabF, which is crucial in the synthesis of fatty acids in bacteria. By blocking this process, the antibiotic prevents the bacteria from producing the fatty acids necessary for the formation of cell membranes, thereby inhibiting their growth and reproduction.
Related Terms
- Antibiotic: A type of drug used to treat infections caused by bacteria.
- Streptomyces platensis: A species of bacteria from which Platensimycin is derived.
- FabF: An enzyme that is crucial in the synthesis of fatty acids in bacteria.
- Fatty acids: Organic compounds that are important components of lipids, which in turn are essential components of all cells.
See Also
External links
- Medical encyclopedia article on Platensimycin
- Wikipedia's article - Platensimycin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski